{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:58:05Z","timestamp":1785481085924,"version":"3.56.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40123-026-01427-9","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T04:53:20Z","timestamp":1782017600000},"page":"2519-2543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Near-Infrared and Red-Light Photobiomodulation for Ocular Aging and Diseases: A Narrative Review"],"prefix":"10.1007","volume":"15","author":[{"given":"Ethan","family":"Waisberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Yaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2410-6366","authenticated-orcid":false,"given":"Giulia","family":"Coco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Gonzalez-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giannaccare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"1427_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1590\/abd1806-4841.20142519","volume":"89","author":"MEDA Chaves","year":"2014","unstructured":"Chaves MEDA, Ara\u00fajo ARD, Piancastelli ACC, Pinotti M. Effects of low-power light therapy on wound healing: LASER x LED. An Bras Dermatol. 2014;89:616\u201323.","journal-title":"An Bras Dermatol"},{"key":"1427_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1161\/STROKEAHA.106.478230","volume":"38","author":"Y Lampl","year":"2007","unstructured":"Lampl Y, et\u00a0al. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera effectiveness and safety trial-1 (NEST-1). Stroke. 2007;38:1843\u20139.","journal-title":"Stroke"},{"key":"1427_CR3","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1093\/hmg\/10.20.2269","volume":"10","author":"G Clarke","year":"2001","unstructured":"Clarke G. Inherited neurodegenerative diseases: the one-hit model of neurodegeneration. Hum Mol Genet. 2001;10:2269\u201375.","journal-title":"Hum Mol Genet"},{"key":"1427_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4103\/JCAS.JCAS_218_20","volume":"14","author":"J Pillai","year":"2021","unstructured":"Pillai J, Mysore V. Role of low-level light therapy (LLLT) in androgenetic alopecia. J Cutan Aesthet Surg. 2021;14:385.","journal-title":"J Cutan Aesthet Surg"},{"key":"1427_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/EB.S21391","author":"F Gonzalez-Lima","year":"2011","unstructured":"Gonzalez-Lima F, Rojas Julio C. Low-level light therapy of the eye and brain. Eye Brain. 2011. https:\/\/doi.org\/10.2147\/EB.S21391.","journal-title":"Eye Brain"},{"key":"1427_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1089\/pho.2015.9848","volume":"33","author":"JJ Anders","year":"2015","unstructured":"Anders JJ, Lanzafame RJ, Arany PR. Low-level light\/laser therapy versus photobiomodulation therapy. Photomed Laser Surg. 2015;33:183\u20134.","journal-title":"Photomed Laser Surg"},{"key":"1427_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.mito.2004.07.033","volume":"4","author":"JT Eells","year":"2004","unstructured":"Eells JT, et\u00a0al. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion. 2004;4:559\u201367.","journal-title":"Mitochondrion"},{"key":"1427_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-3-030-54564-2_9","volume-title":"Modern approaches to augmentation of brain function","author":"F Gonzalez-Lima","year":"2021","unstructured":"Gonzalez-Lima F. Neuroprotection and neurocognitive augmentation by photobiomodulation. In: Opris I, Lebedev AM, Casanova FM, editors. Modern approaches to augmentation of brain function. Cham: Springer International Publishing; 2021. p. 165\u2013207. https:\/\/doi.org\/10.1007\/978-3-030-54564-2_9."},{"key":"1427_CR9","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/oxfordhb\/9780198832256.013.10","volume-title":"The Oxford handbook of transcranial stimulation","author":"X Wang","year":"2022","unstructured":"Wang X, Gonzalez-Lima F, Liu H, et\u00a0al. Transcranial infrared laser stimulation. In: Wassermann EM, editor., et\u00a0al., The Oxford Handbook of Transcranial Stimulation. Oxford University Press; 2022. p. 276\u201398. https:\/\/doi.org\/10.1093\/oxfordhb\/9780198832256.013.10."},{"key":"1427_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1011-1344(98)00219-X","volume":"49","author":"T Karu","year":"1999","unstructured":"Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B Biol. 1999;49:1\u201317.","journal-title":"J Photochem Photobiol B Biol"},{"key":"1427_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/pho.2005.23.355","volume":"23","author":"TI Karu","year":"2005","unstructured":"Karu TI, Kolyakov SF. Exact action spectra for cellular responses relevant to phototherapy. Photomed Laser Surg. 2005;23:355\u201361.","journal-title":"Photomed Laser Surg"},{"key":"1427_CR12","first-page":"1245","volume":"291","author":"TI Karu","year":"1986","unstructured":"Karu TI. Molecular mechanism of the therapeutic effect of low-intensity laser irradiation. Dokl Akad Nauk SSSR. 1986;291:1245\u20139.","journal-title":"Dokl Akad Nauk SSSR"},{"key":"1427_CR13","doi-asserted-by":"publisher","first-page":"30540","DOI":"10.1038\/srep30540","volume":"6","author":"X Wang","year":"2016","unstructured":"Wang X, Tian F, Soni SS, Gonzalez-Lima F, Liu H. Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser. Sci Rep. 2016;6:30540.","journal-title":"Sci Rep"},{"key":"1427_CR14","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1177\/0271678X17691783","volume":"37","author":"X Wang","year":"2017","unstructured":"Wang X, et\u00a0al. Up-regulation of cerebral cytochrome-c-oxidase and hemodynamics by transcranial infrared laser stimulation: a broadband near-infrared spectroscopy study. J Cereb Blood Flow Metab. 2017;37:3789\u2013802.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1427_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1109\/JSTQE.2016.2561201","volume":"22","author":"LF De Freitas","year":"2016","unstructured":"De Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22:348\u201364.","journal-title":"IEEE J Sel Top Quantum Electron"},{"key":"1427_CR16","first-page":"58","volume":"5","author":"S Farivar","year":"2014","unstructured":"Farivar S, Malekshahabi T, Shiari R. Biological effects of low level laser therapy. J Lasers Med Sci. 2014;5:58\u201362.","journal-title":"J Lasers Med Sci"},{"key":"1427_CR17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.bcp.2013.06.012","volume":"86","author":"JC Rojas","year":"2013","unstructured":"Rojas JC, Gonzalez-Lima F. Neurological and psychological applications of transcranial lasers and LEDs. Biochem Pharmacol. 2013;86:447\u201357.","journal-title":"Biochem Pharmacol"},{"key":"1427_CR18","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jphotobiol.2014.07.021","volume":"140","author":"S Passarella","year":"2014","unstructured":"Passarella S, Karu T. Absorption of monochromatic and narrow band radiation in the visible and near IR by both mitochondrial and non-mitochondrial photoacceptors results in photobiomodulation. J Photochem Photobiol B Biol. 2014;140:344\u201358.","journal-title":"J Photochem Photobiol B Biol"},{"key":"1427_CR19","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/ncomms1742","volume":"3","author":"MG Shapiro","year":"2012","unstructured":"Shapiro MG, Homma K, Villarreal S, Richter C-P, Bezanilla F. Infrared light excites cells by changing their electrical capacitance. Nat Commun. 2012;3:736.","journal-title":"Nat Commun"},{"key":"1427_CR20","doi-asserted-by":"publisher","first-page":"1006031","DOI":"10.3389\/fnins.2022.1006031","volume":"16","author":"FDS Cardoso","year":"2022","unstructured":"Cardoso FDS, Salehpour F, Coimbra NC, Gonzalez-Lima F, Gomes Da Silva S. Photobiomodulation for the treatment of neuroinflammation: a systematic review of controlled laboratory animal studies. Front Neurosci. 2022;16:1006031.","journal-title":"Front Neurosci"},{"key":"1427_CR21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12035-021-02606-4","volume":"59","author":"F Dos Santos Cardoso","year":"2022","unstructured":"Dos Santos Cardoso F, Mansur FCB, Ara\u00fajo BHS, Gonzalez-Lima F, Gomes Da Silva S. Photobiomodulation improves the inflammatory response and intracellular signaling proteins linked to vascular function and cell survival in the brain of aged rats. Mol Neurobiol. 2022;59:420\u20138.","journal-title":"Mol Neurobiol"},{"key":"1427_CR22","doi-asserted-by":"publisher","first-page":"683127","DOI":"10.3389\/fncel.2021.683127","volume":"15","author":"FDS Cardoso","year":"2021","unstructured":"Cardoso FDS, Mansur FCB, Lopes-Martins R\u00c1B, Gonzalez-Lima F, Gomes Da Silva S. Transcranial laser photobiomodulation improves intracellular signaling linked to cell survival, memory and glucose metabolism in the aged brain: a preliminary study. Front Cell Neurosci. 2021;15:683127.","journal-title":"Front Cell Neurosci"},{"key":"1427_CR23","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1007\/s12035-020-02247-z","volume":"58","author":"F Dos Santos Cardoso","year":"2021","unstructured":"Dos Santos Cardoso F, et\u00a0al. Effects of chronic photobiomodulation with transcranial near-infrared laser on brain metabolomics of young and aged rats. Mol Neurobiol. 2021;58:2256\u201368.","journal-title":"Mol Neurobiol"},{"key":"1427_CR24","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.drudis.2014.05.010","volume":"19","author":"NN Osborne","year":"2014","unstructured":"Osborne NN, \u00c1lvarez CN, Del Olmo Aguado S. Targeting mitochondrial dysfunction as in aging and glaucoma. Drug Discov Today. 2014;19:1613\u201322.","journal-title":"Drug Discov Today"},{"key":"1427_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/bjo.83.2.231","volume":"83","author":"RM Andrews","year":"1999","unstructured":"Andrews RM, Griffiths PG, Johnson MA, Turnbull DM. Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br J Ophthalmol. 1999;83:231\u20135.","journal-title":"Br J Ophthalmol"},{"key":"1427_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.08.004","volume":"38","author":"J Wang","year":"2014","unstructured":"Wang J, Deretic D. Molecular complexes that direct rhodopsin transport to primary cilia. Prog Retin Eye Res. 2014;38:1\u201319.","journal-title":"Prog Retin Eye Res"},{"key":"1427_CR27","first-page":"3117","volume":"41","author":"RA Linsenmeier","year":"2000","unstructured":"Linsenmeier RA, Padnick-Silver L. Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. Invest Ophthalmol Vis Sci. 2000;41:3117\u201323.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1427_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neurobiolaging.2017.01.001","volume":"52","author":"C Sivapathasuntharam","year":"2017","unstructured":"Sivapathasuntharam C, Sivaprasad S, Hogg C, Jeffery G. Aging retinal function is improved by near infrared light (670 nm) that is associated with corrected mitochondrial decline. Neurobiol Aging. 2017;52:66\u201370.","journal-title":"Neurobiol Aging"},{"key":"1427_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1017\/S0952523807070204","volume":"24","author":"A Cunea","year":"2007","unstructured":"Cunea A, Jeffery G. The ageing photoreceptor. Vis Neurosci. 2007;24:151\u20135.","journal-title":"Vis Neurosci"},{"key":"1427_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/eye.2001.140","volume":"15","author":"CA Curcio","year":"2001","unstructured":"Curcio CA. Photoreceptor topography in ageing and age-related maculopathy. Eye. 2001;15:376\u201383.","journal-title":"Eye"},{"key":"1427_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mito.2016.11.009","volume":"36","author":"NN Osborne","year":"2017","unstructured":"Osborne NN, N\u00fa\u00f1ez-\u00c1lvarez C, Del Olmo-Aguado S, Merrayo-Lloves J. Visual light effects on mitochondria: the potential implications in relation to glaucoma. Mitochondrion. 2017;36:29\u201335.","journal-title":"Mitochondrion"},{"key":"1427_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuint.2019.02.018","volume":"125","author":"C N\u00fa\u00f1ez-\u00c1lvarez","year":"2019","unstructured":"N\u00fa\u00f1ez-\u00c1lvarez C, Osborne NN. Blue light exacerbates and red light counteracts negative insults to retinal ganglion cells in situ and R28 cells in vitro. Neurochem Int. 2019;125:187\u201396.","journal-title":"Neurochem Int"},{"key":"1427_CR33","doi-asserted-by":"publisher","first-page":"20150073","DOI":"10.1098\/rsbl.2015.0073","volume":"11","author":"R Begum","year":"2015","unstructured":"Begum R, et\u00a0al. Near-infrared light increases ATP, extends lifespan and improves mobility in aged Drosophila melanogaster. Biol Lett. 2015;11:20150073.","journal-title":"Biol Lett"},{"key":"1427_CR34","doi-asserted-by":"publisher","first-page":"e0166531","DOI":"10.1371\/journal.pone.0166531","volume":"11","author":"MB Powner","year":"2016","unstructured":"Powner MB, Salt TE, Hogg C, Jeffery G. Improving mitochondrial function protects bumblebees from neonicotinoid pesticides. PLoS One. 2016;11:e0166531.","journal-title":"PLoS One"},{"issue":"2","key":"1427_CR35","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, et\u00a0al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106\u201316. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1.","journal-title":"Lancet Glob Health"},{"key":"1427_CR36","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1523\/JNEUROSCI.0190-15.2015","volume":"35","author":"MR Terluk","year":"2015","unstructured":"Terluk MR, et\u00a0al. Investigating mitochondria as a target for treating age-related macular degeneration. J Neurosci. 2015;35:7304\u201311.","journal-title":"J Neurosci"},{"key":"1427_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/pho.2007.2132","volume":"26","author":"BT Ivandic","year":"2008","unstructured":"Ivandic BT, Ivandic T. Low-level laser therapy improves vision in patients with age-related macular degeneration. Photomed Laser Surg. 2008;26:241\u20135.","journal-title":"Photomed Laser Surg"},{"issue":"14","key":"1427_CR38","first-page":"2049","volume":"53","author":"G Merry","year":"2012","unstructured":"Merry G, Dotson R, Devenyi R, Markowitz SRS. Photobiomodulation as a new treatment for dry age related macular degeneration. Results from the Toronto and Oak Ridge Photobimodulation Study in AMD (TORPA). Invest Ophthalmol Vis Sci. 2012;53(14):2049.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"1427_CR39","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1111\/aos.13354","volume":"95","author":"GF Merry","year":"2017","unstructured":"Merry GF, Munk MR, Dotson RS, Walker MG, Devenyi RG. Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration. Acta Ophthalmologica. 2017;95(4):e270\u20137.","journal-title":"Acta Ophthalmologica"},{"key":"1427_CR40","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/IAE.0000000000002632","volume":"40","author":"SN Markowitz","year":"2020","unstructured":"Markowitz SN, et\u00a0al. A double-masked, randomized, sham-controlled, single-center study with photobiomodulation for the treatment of dry age-related macular degeneration. Retina. 2020;40:1471\u201382.","journal-title":"Retina"},{"key":"1427_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40123-022-00640-6","volume":"12","author":"B Burton","year":"2023","unstructured":"Burton B, et\u00a0al. LIGHTSITE II randomized multicenter trial: evaluation of multiwavelength photobiomodulation in non-exudative Age-related macular degeneration. Ophthalmol Ther. 2023;12:953\u201368.","journal-title":"Ophthalmol Ther"},{"key":"1427_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/IAE.0000000000003980","volume":"44","author":"D Boyer","year":"2024","unstructured":"Boyer D, et\u00a0al. LIGHTSITE III: 13-month efficacy and safety evaluation of multiwavelength photobiomodulation in nonexudative (dry) age-related macular degeneration using the lumithera valeda light delivery system. Retina. 2024;44:487\u201397.","journal-title":"Retina"},{"key":"1427_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000004822","author":"GJ Jaffe","year":"2026","unstructured":"Jaffe GJ, Boyer D, Hu A, Warrow D, Xavier S, Gonzalez V, et\u00a0al. Long-term efficacy and safety of photobiomodulation in dry age-related macular degeneration (LIGHTSITE III: 24-month analysis). Retina. 2026. https:\/\/doi.org\/10.1097\/IAE.0000000000004822. (Online ahead of print.).","journal-title":"Retina"},{"key":"1427_CR44","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/jcm9041001","volume":"9","author":"MK Grewal","year":"2020","unstructured":"Grewal MK, et\u00a0al. A pilot study evaluating the effects of 670 nm photobiomodulation in healthy ageing and age-related macular degeneration. J Clin Med. 2020;9:1001.","journal-title":"J Clin Med"},{"issue":"8","key":"1427_CR45","first-page":"233","volume":"62","author":"Clark Tedford","year":"2021","unstructured":"Tedford Clark, Montzka Dan, Munk Marion Ronit, Pollack Scott, Perich Maverick, Perich Tanya, et\u00a0al. Improvement of visual function following multi-wavelength photobiomodulation with the valeda light delivery system on electroretinography (ERG) and best corrected visual acuity (BCVA) in dry age-related macular degeneration in the ELECTROLIGHT study (Interim Analysis). Invest Ophthalmol Vis Sci. 2021;62(8):233.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1427_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/s40123-024-01030-w","author":"E Borrelli","year":"2024","unstructured":"Borrelli E, et\u00a0al. Safety, tolerability, and short-term efficacy of low-level light therapy for dry age-related macular degeneration. Ophthalmol Ther. 2024. https:\/\/doi.org\/10.1007\/s40123-024-01030-w.","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"1427_CR47","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1097\/IAE.0000000000004265","volume":"44","author":"N Feltgen","year":"2024","unstructured":"Feltgen N, Ach T, Bartz-Schmidt U, Bechrakis N, Eter N, Hattenbach L, et\u00a0al. Correspondence. Retina. 2024;44(12):e81\u20133. https:\/\/doi.org\/10.1097\/IAE.0000000000004265.","journal-title":"Retina"},{"issue":"12","key":"1427_CR48","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1097\/IAE.0000000000004266","volume":"44","author":"DS Boyer","year":"2024","unstructured":"Boyer DS, Munk MR, Tedford SE, Croissant CL, R\u00fcckert R, Tedford CE. Reply. Retina. 2024;44(12):e83\u20137. https:\/\/doi.org\/10.1097\/IAE.0000000000004266.","journal-title":"Retina"},{"issue":"3","key":"1427_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/jamaophthalmol.2025.0077","volume":"143","author":"SR Sadda","year":"2025","unstructured":"Sadda SR. Photobiomodulation for age-related macular degeneration. JAMA Ophthalmol. 2025;143(3):195\u20136. https:\/\/doi.org\/10.1001\/jamaophthalmol.2025.0077.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"1427_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40942-024-00569-x","volume":"10","author":"TNO Rassi","year":"2024","unstructured":"Rassi TNO, Barbosa LM, Pereira S, Novais EA, Penha F, Roisman L, et\u00a0al. Photobiomodulation efficacy in age-related macular degeneration: a systematic review and meta-analysis of randomized clinical trials. Int J Retina Vitreous. 2024;10(1):54. https:\/\/doi.org\/10.1186\/s40942-024-00569-x.","journal-title":"Int J Retina Vitreous"},{"issue":"5","key":"1427_CR51","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s40123-025-01119-w","volume":"14","author":"KY Chen","year":"2025","unstructured":"Chen KY, Lee HK, Chan HC, Chan CM. Is multiwavelength photobiomodulation effective and safe for age-related macular degeneration? A systematic review and meta-analysis. Ophthalmol Ther. 2025;14(5):969\u201387. https:\/\/doi.org\/10.1007\/s40123-025-01119-w.","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"1427_CR52","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, et\u00a0al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334\u201365. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.003.","journal-title":"Ocul Surf"},{"key":"1427_CR53","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/08164622.2021.1878866","volume":"104","author":"M Markoulli","year":"2021","unstructured":"Markoulli M, Chandramohan N, Papas EB. Photobiomodulation (low-level light therapy) and dry eye disease. Clin Exp Optom. 2021;104:561\u20136.","journal-title":"Clin Exp Optom"},{"key":"1427_CR54","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1038\/s41598-022-07427-6","volume":"12","author":"Y Park","year":"2022","unstructured":"Park Y, Kim H, Kim S, Cho KJ. Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial. Sci Rep. 2022;12:3575.","journal-title":"Sci Rep"},{"key":"1427_CR55","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40123-022-00619-3","volume":"12","author":"G Giannaccare","year":"2023","unstructured":"Giannaccare G, et\u00a0al. Serial sessions of a novel low-level light therapy device for home treatment of dry eye disease. Ophthalmol Ther. 2023;12:459\u201368.","journal-title":"Ophthalmol Ther"},{"key":"1427_CR56","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2023-323920","author":"G Giannaccare","year":"2023","unstructured":"Giannaccare G, et\u00a0al. Outcomes of low-level light therapy before and after cataract surgery for the prophylaxis of postoperative dry eye: a prospective randomised double-masked controlled clinical trial. Br J Ophthalmol. 2023. https:\/\/doi.org\/10.1136\/bjo-2023-323920.","journal-title":"Br J Ophthalmol"},{"key":"1427_CR57","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/ICO.0000000000002997","volume":"42","author":"G Giannaccare","year":"2023","unstructured":"Giannaccare G, et\u00a0al. Low-level light therapy versus intense pulsed light for the treatment of meibomian gland dysfunction: preliminary results from a prospective randomized comparative study. Cornea. 2023;42:141\u20134.","journal-title":"Cornea"},{"key":"1427_CR58","doi-asserted-by":"publisher","first-page":"102456","DOI":"10.1016\/j.clae.2025.102456","volume":"48","author":"JCB Chiang","year":"2025","unstructured":"Chiang JCB, et\u00a0al. Low-level light therapy alone versus combination therapy with intense pulsed light in the treatment of dry eye disease with meibomian gland dysfunction: a randomised paired-eye and mechanism of action trial. Contact Lens Anterior Eye. 2025;48:102456.","journal-title":"Contact Lens Anterior Eye"},{"issue":"7","key":"1427_CR59","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1111\/opo.13371","volume":"44","author":"A Antwi","year":"2024","unstructured":"Antwi A, Schill AW, Redfern R, Ritchey ER. Effect of low-level light therapy in individuals with dry eye disease. Ophthalmic Physiol Opt. 2024;44(7):1464\u201371. https:\/\/doi.org\/10.1111\/opo.13371.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"1427_CR60","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.clae.2024.102344","volume":"48","author":"KE Chan","year":"2025","unstructured":"Chan KE, Lau BSR, Lim BXH, Du R, Giannaccare G, Tong L, et\u00a0al. Low-level light therapy and intense pulse light therapy in meibomian gland dysfunction. A systematic review and meta-analysis. Cont Lens Anterior Eye. 2025;48(2):102344. https:\/\/doi.org\/10.1016\/j.clae.2024.102344.","journal-title":"Cont Lens Anterior Eye"},{"key":"1427_CR61","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ajo.2025.05.039","volume":"279","author":"L Jones","year":"2025","unstructured":"Jones L, Downie LE, Korb D, et\u00a0al. TFOS DEWS III: management and therapy. Am J Ophthalmol. 2025;279:160\u2013215. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.039.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1427_CR62","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/bjo-2024-325427","volume":"109","author":"J Liang","year":"2025","unstructured":"Liang J, Pu Y, Chen J, Liu M, Ouyang B, Jin Z, et\u00a0al. Global prevalence, trend and projection of myopia in children and adolescents from 1990 to 2050: a comprehensive systematic review and meta-analysis. Br J Ophthalmol. 2025;109(3):362\u201371. https:\/\/doi.org\/10.1136\/bjo-2024-325427.","journal-title":"Br J Ophthalmol"},{"key":"1427_CR63","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ophtha.2012.11.009","volume":"120","author":"P-C Wu","year":"2013","unstructured":"Wu P-C, Tsai C-L, Wu H-L, Yang Y-H, Kuo H-K. Outdoor activity during class recess reduces myopia onset and progression in school children. Ophthalmology. 2013;120:1080\u20135.","journal-title":"Ophthalmology"},{"key":"1427_CR64","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1001\/archopht.120.5.620","volume":"120","author":"S-M Saw","year":"2002","unstructured":"Saw S-M. Near-work activity, night-lights, and myopia in the Singapore-China study. Arch Ophthalmol. 2002;120:620.","journal-title":"Arch Ophthalmol"},{"key":"1427_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2004.06.004","volume":"24","author":"I Morgan","year":"2005","unstructured":"Morgan I, Rose K. How genetic is school myopia? Prog Retin Eye Res. 2005;24:1\u201338.","journal-title":"Prog Retin Eye Res"},{"key":"1427_CR66","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","volume":"129","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, et\u00a0al. Effect of repeated low-level red-light therapy for myopia control in children. Ophthalmology. 2022;129:509\u201319.","journal-title":"Ophthalmology"},{"key":"1427_CR67","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/opo.12939","volume":"42","author":"L Zhou","year":"2022","unstructured":"Zhou L, Xing C, Qiang W, Hua C, Tong L. Low\u2010intensity, long\u2010wavelength red light slows the progression of myopia in children: an Eastern China\u2010based cohort. Ophthalmic Physiol Opt. 2022;42:335\u201344.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1427_CR68","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1001\/jamaophthalmol.2024.0801","volume":"142","author":"K Cao","year":"2024","unstructured":"Cao K, et\u00a0al. Daily low-level red light for spherical equivalent error and axial length in children with myopia: a randomized clinical trial. JAMA Ophthalmol. 2024;142:560.","journal-title":"JAMA Ophthalmol"},{"key":"1427_CR69","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/lsm.23204","volume":"52","author":"DR Mokoena","year":"2020","unstructured":"Mokoena DR, Houreld NN, Dhilip Kumar SS, Abrahamse H. Photobiomodulation at 660 nm stimulates fibroblast differentiation. Lasers Surg Med. 2020;52:671\u201381.","journal-title":"Lasers Surg Med"},{"key":"1427_CR70","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jphotobiol.2018.10.011","volume":"189","author":"D Mokoena","year":"2018","unstructured":"Mokoena D, Dhilip Kumar SS, Houreld NN, Abrahamse H. Role of photobiomodulation on the activation of the Smad pathway via TGF-\u03b2 in wound healing. J Photochem Photobiol B Biol. 2018;189:138\u201344.","journal-title":"J Photochem Photobiol B Biol"},{"key":"1427_CR71","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s40123-022-00490-2","volume":"11","author":"P Zhang","year":"2022","unstructured":"Zhang P, Zhu H. Light signaling and myopia development: a review. Ophthalmol Ther. 2022;11:939\u201357.","journal-title":"Ophthalmol Ther"},{"key":"1427_CR72","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/ceo.14149","volume":"50","author":"R Xiong","year":"2022","unstructured":"Xiong R, et\u00a0al. Sustained and rebound effect of repeated low-level red-light therapy on myopia control: a 2-year post-trial follow-up study. Clin Exp Ophthalmol. 2022;50:1013\u201324.","journal-title":"Clin Exp Ophthalmol"},{"key":"1427_CR73","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00417-022-05794-4","volume":"261","author":"H Chen","year":"2023","unstructured":"Chen H, et\u00a0al. Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol. 2023;261:575\u201384.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1427_CR74","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","volume":"130","author":"J Dong","year":"2023","unstructured":"Dong J, Zhu Z, Xu H, He M. Myopia control effect of repeated low-level red-light therapy in Chinese children. Ophthalmology. 2023;130:198\u2013204.","journal-title":"Ophthalmology"},{"key":"1427_CR75","doi-asserted-by":"publisher","DOI":"10.1080\/09286586.2025.2500020","author":"N Deen","year":"2025","unstructured":"Deen N, Zhu Z, Qi Z, et\u00a0al. Three-month interim analyses of repeated low-level red-light therapy in myopia control in schoolchildren: a pilot multi-ethnic randomized controlled trial. Ophthalmic Epidemiol. 2025. https:\/\/doi.org\/10.1080\/09286586.2025.2500020.","journal-title":"Ophthalmic Epidemiol"},{"key":"1427_CR76","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/opo.13202","volume":"43","author":"C Zhao","year":"2023","unstructured":"Zhao C, Ni Y, Zeng J. Effect of red-light therapy on retinal and choroidal blood perfusion in myopic children. Ophthalmic Physiol Opt. 2023;43:1427\u201337.","journal-title":"Ophthalmic Physiol Opt"},{"key":"1427_CR77","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s40123-022-00644-2","volume":"12","author":"W Wang","year":"2023","unstructured":"Wang W, et\u00a0al. Clinically significant axial shortening in myopic children after repeated low-level red light therapy: a retrospective multicenter analysis. Ophthalmol Ther. 2023;12:999\u20131011.","journal-title":"Ophthalmol Ther"},{"key":"1427_CR78","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ophtha.2023.08.020","volume":"131","author":"W Zhou","year":"2024","unstructured":"Zhou W, et\u00a0al. Efficacy of different powers of low-level red light in children for myopia control. Ophthalmology. 2024;131:48\u201357.","journal-title":"Ophthalmology"},{"issue":"2","key":"1427_CR79","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ophtha.2015.07.004","volume":"123","author":"A Chia","year":"2016","unstructured":"Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391\u20139. https:\/\/doi.org\/10.1016\/j.ophtha.2015.07.004.","journal-title":"Ophthalmology"},{"issue":"1","key":"1427_CR80","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, et\u00a0al. Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology. 2019;126(1):113\u201324. https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.029.","journal-title":"Ophthalmology"},{"issue":"3","key":"1427_CR81","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","volume":"129","author":"JC Yam","year":"2022","unstructured":"Yam JC, Zhang XJ, Zhang Y, Wang YM, Tang SM, Li FF, et\u00a0al. Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report. Ophthalmology. 2022;129(3):308\u201321. https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.002.","journal-title":"Ophthalmology"},{"issue":"11","key":"1427_CR82","doi-asserted-by":"publisher","first-page":"7077","DOI":"10.1167\/iovs.12-10565","volume":"53","author":"P Cho","year":"2012","unstructured":"Cho P, Cheung SW. Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077\u201385. https:\/\/doi.org\/10.1167\/iovs.12-10565.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1427_CR83","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/opo.12453","volume":"38","author":"T Hiraoka","year":"2018","unstructured":"Hiraoka T, Kakita T, Okamoto F, Takahashi H, Oshika T. Safety and efficacy following 10-years of overnight orthokeratology for myopia control. Ophthalmic Physiol Opt. 2018;38(3):281\u20139. https:\/\/doi.org\/10.1111\/opo.12453.","journal-title":"Ophthalmic Physiol Opt"},{"issue":"3","key":"1427_CR84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1136\/bjophthalmol-2018-313739","volume":"104","author":"CSY Lam","year":"2020","unstructured":"Lam CSY, Tang WC, Tse DY, Tang YY, To CH. Defocus incorporated multiple segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020;104(3):363\u20138. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313739.","journal-title":"Br J Ophthalmol"},{"key":"1427_CR85","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2022-323732","author":"CSY Lam","year":"2023","unstructured":"Lam CSY, Tang WC, Zhang HY, et\u00a0al. Long-term myopia control effect and safety in children wearing DIMS spectacle lenses for 6 years. Br J Ophthalmol. 2023. https:\/\/doi.org\/10.1136\/bjo-2022-323732.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1427_CR86","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","volume":"140","author":"J Bao","year":"2022","unstructured":"Bao J, Yang A, Huang Y, et\u00a0al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA Ophthalmol. 2022;140(5):472\u20138. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.0401.","journal-title":"JAMA Ophthalmol"},{"key":"1427_CR87","doi-asserted-by":"publisher","first-page":"100124","DOI":"10.1016\/j.apjo.2024.100124","volume":"13","author":"Y Chen","year":"2024","unstructured":"Chen Y, et\u00a0al. Safety of repeated low-level red-light therapy for myopia: a systematic review. Asia Pac J Ophthalmol. 2024;13:100124.","journal-title":"Asia Pac J Ophthalmol"},{"key":"1427_CR88","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/978-94-007-2869-1_14","volume-title":"Advances in mitochondrial medicine","author":"H-C Lee","year":"2012","unstructured":"Lee H-C, Wei Y-H. Mitochondria and aging. In: Scatena R, Bottoni P, Giardina B, editors. Advances in Mitochondrial Medicine, vol. 942. Dordrecht: Springer Netherlands; 2012. p. 311\u201327."},{"key":"1427_CR89","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1093\/gerona\/glaa155","volume":"75","author":"H Shinhmar","year":"2020","unstructured":"Shinhmar H, et\u00a0al. Optically improved mitochondrial function redeems aged human visual decline. J Gerontol Ser A. 2020;75:e49\u201352.","journal-title":"J Gerontol Ser A"},{"key":"1427_CR90","doi-asserted-by":"publisher","first-page":"e0139003","DOI":"10.1371\/journal.pone.0139003","volume":"10","author":"A Saliba","year":"2015","unstructured":"Saliba A, et\u00a0al. Photobiomodulation mitigates diabetes-induced retinopathy by direct and indirect mechanisms: evidence from intervention studies in pigmented mice. PLoS ONE. 2015;10:e0139003.","journal-title":"PLoS ONE"},{"key":"1427_CR91","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1167\/iovs.12-11018","volume":"54","author":"J Tang","year":"2013","unstructured":"Tang J, et\u00a0al. Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro. Invest Ophthalmol Vis Sci. 2013;54:3681.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1427_CR92","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2337\/db17-0803","volume":"67","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, et\u00a0al. Photobiomodulation inhibits long-term structural and functional lesions of diabetic retinopathy. Diabetes. 2018;67:291\u20138.","journal-title":"Diabetes"},{"key":"1427_CR93","doi-asserted-by":"publisher","first-page":"110218","DOI":"10.1016\/j.exer.2024.110218","volume":"251","author":"J Ge","year":"2025","unstructured":"Ge J, et\u00a0al. Photobiomodulation inhibits retinal degeneration in diabetic mice through modulation of stem cell mobilization and gene expression. Exp Eye Res. 2025;251:110218.","journal-title":"Exp Eye Res"},{"key":"1427_CR94","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1136\/bjophthalmol-2013-304477","volume":"98","author":"J Tang","year":"2014","unstructured":"Tang J, Herda AA, Kern TS. Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema. Br J Ophthalmol. 2014;98:1013\u20135.","journal-title":"Br J Ophthalmol"},{"key":"1427_CR95","first-page":"932","volume":"58","author":"JT Eells","year":"2017","unstructured":"Eells JT, Gopalakrishnan S, Connor TB. 670 nm photomodulation as a therapy for diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci. 2017;58:932.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1427_CR96","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.oret.2021.10.003","volume":"6","author":"JE Kim","year":"2022","unstructured":"Kim JE, et\u00a0al. A randomized trial of photobiomodulation therapy for center-involved diabetic macular edema with good visual acuity (protocol AE). Ophthalmology Retina. 2022;6:298\u2013307.","journal-title":"Ophthalmology Retina"},{"key":"1427_CR97","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1089\/pho.2013.3535","volume":"32","author":"BT Ivandic","year":"2014","unstructured":"Ivandic BT, Ivandic T. Low-level laser therapy improves vision in a patient with Retinitis Pigmentosa. Photomed Laser Surg. 2014;32:181\u20134.","journal-title":"Photomed Laser Surg"},{"key":"1427_CR98","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.2147\/OPTH.S483722","volume":"18","author":"R Siqueira","year":"2024","unstructured":"Siqueira R, Pinho T, Brand\u00e3o C. Short-term results of multiwavelength photobiomodulation in retinitis pigmentosa. OPTH. 2024;18:3715\u201324.","journal-title":"OPTH"},{"key":"1427_CR99","doi-asserted-by":"publisher","DOI":"10.1177\/11206721231199779","author":"E Waisberg","year":"2023","unstructured":"Waisberg E, et\u00a0al. Precisional modulation of translaminar pressure gradients for ophthalmic diseases. Eur J Ophthalmol. 2023. https:\/\/doi.org\/10.1177\/11206721231199779.","journal-title":"Eur J Ophthalmol"},{"key":"1427_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-023-02448-5","author":"E Waisberg","year":"2023","unstructured":"Waisberg E, Ong J, Masalkhi M, Lee AG, Berdahl J. Wearable, dropless reduction in intraocular pressure as an emerging therapy for glaucoma. Eye (Lond). 2023. https:\/\/doi.org\/10.1038\/s41433-023-02448-5.","journal-title":"Eye (Lond)"},{"key":"1427_CR101","doi-asserted-by":"publisher","first-page":"1184060","DOI":"10.3389\/fphys.2023.1184060","volume":"14","author":"G Kuang","year":"2023","unstructured":"Kuang G, Halimitabrizi M, Edziah A-A, Salowe R, O\u2019Brien JM. The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review. Front Physiol. 2023;14:1184060.","journal-title":"Front Physiol"},{"key":"1427_CR102","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/php.12606","volume":"92","author":"K Beirne","year":"2016","unstructured":"Beirne K, Rozanowska M, Votruba M. Red light treatment in an axotomy model of neurodegeneration. Photochem Photobiol. 2016;92:624\u201331.","journal-title":"Photochem Photobiol"},{"issue":"2","key":"1427_CR103","first-page":"377","volume":"5","author":"Yadollah Eslami","year":"2021","unstructured":"Eslami Yadollah, Lazar Albert, Tabatabaei Seyed Mehdi, Najafabadi Masoud Soltani, Lazar Antoine, Eslami Mohammad Soroush, et\u00a0al. The effect of low-level laser therapy on visual function in glaucomatous patients. J Clin Ophthalmol. 2021;5(2):377.","journal-title":"J Clin Ophthalmol"},{"key":"1427_CR104","doi-asserted-by":"publisher","DOI":"10.2147\/EB.S272343","author":"E Waisberg","year":"2021","unstructured":"Waisberg E, Micieli JA. Neuro-ophthalmological optic nerve cupping: an overview. Eye Brain. 2021. https:\/\/doi.org\/10.2147\/EB.S272343.","journal-title":"Eye Brain"},{"key":"1427_CR105","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.0534746100","volume":"100","author":"JT Eells","year":"2003","unstructured":"Eells JT, et\u00a0al. Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc Natl Acad Sci U S A. 2003;100:3439\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1427_CR106","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/sj.eye.6701591","volume":"18","author":"NJ Newman","year":"2004","unstructured":"Newman NJ, Biousse V. Hereditary optic neuropathies. Eye. 2004;18:1144\u201360.","journal-title":"Eye"},{"key":"1427_CR107","first-page":"263300402110290","volume":"2","author":"WSV Ng","year":"2021","unstructured":"Ng WSV, et\u00a0al. New avenues for therapy in mitochondrial optic neuropathies. Ther Adv Rare Dis. 2021;2:263300402110290.","journal-title":"Ther Adv Rare Dis"},{"key":"1427_CR108","doi-asserted-by":"publisher","first-page":"13511","DOI":"10.1523\/JNEUROSCI.3457-08.2008","volume":"28","author":"JC Rojas","year":"2008","unstructured":"Rojas JC, Lee J, John JM, Gonzalez-Lima F. Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy. J Neurosci. 2008;28:13511\u201321.","journal-title":"J Neurosci"},{"key":"1427_CR109","unstructured":"Near-infrared light-emitting diode (NIR-LED) therapy for Leber\u2019s hereditary optic neuropathy (LHON) (LHON). Clinical Trials.Gov https:\/\/www.clinicaltrials.gov\/study\/NCT01389817."},{"key":"1427_CR110","doi-asserted-by":"publisher","first-page":"e0125631","DOI":"10.1371\/journal.pone.0125631","volume":"10","author":"S Volland","year":"2015","unstructured":"Volland S, Esteve-Rudd J, Hoo J, Yee C, Williams DS. A comparison of some organizational characteristics of the mouse central retina and the human macula. PLoS One. 2015;10:e0125631.","journal-title":"PLoS One"},{"key":"1427_CR111","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s40123-022-00585-w","volume":"11","author":"L Tian","year":"2022","unstructured":"Tian L, et\u00a0al. Investigation of the efficacy and safety of 650 nm low-level red light for myopia control in children: a randomized controlled trial. Ophthalmol Ther. 2022;11:2259\u201370.","journal-title":"Ophthalmol Ther"},{"key":"1427_CR112","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1167\/tvst.13.10.29","volume":"13","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhu M, Yan X, Li M, Xiang Y. The effect of repeated low-level red-light therapy on myopia control and choroid. Transl Vis Sci Technol. 2024;13:29.","journal-title":"Transl Vis Sci Technol"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01427-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-026-01427-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-026-01427-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:04:45Z","timestamp":1785477885000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-026-01427-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":112,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1007\/s40123-026-01427-9","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Andrew G. Lee reports receiving speaker fees from Amgen and Alexion and serving as a consultant for Viridian, Stoke, Catalys, AstraZeneca, and Bristol Myers Squibb. Ethan Waisberg has nothing to disclose. Joshua Ong has nothing to disclose. Luke Yaldo has nothing to disclose. Rahul Kumar has nothing to disclose. Wei Wang has nothing to disclose. Valerio Calabresi has nothing to disclose. Giulia Coco reports receiving speaker fees from Espansione Group. Francisco Gonzalez-Lima has nothing to disclose. Giuseppe Giannaccare reports receiving speaker fees from Espansione Group.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}